[Immunisation schedule of the Pediatric Spanish Association: 2021 recommendations]

Francisco José Álvarez García1, María José Cilleruelo Ortega2, Javier Álvarez Aldeán3

  • 1Centro de Salud de Llanera, Asturias, España; Departamento de Medicina, Universidad de Oviedo, Asturias, España.

Anales De Pediatria
|January 9, 2021
PubMed

Insights

The CAV-AEP recommends an updated childhood immunization schedule in Spain, including hexavalent, pneumococcal, rotavirus, meningococcal B and ACWY vaccines. Key updates include a 6-year booster, Tdap in pregnancy, and universal HPV vaccination for all genders.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Background:

  • The Spanish Association for the Prevention of Accidents (CAV-AEP) annually reviews and publishes optimal immunization schedules for children and adolescents in Spain.
  • Evidence-based recommendations are crucial for maintaining high vaccination coverage and preventing vaccine-preventable diseases.

Purpose of the Study:

  • To present the updated annual immunization schedule recommended by the CAV-AEP for children and adolescents in Spain.
  • To outline specific vaccine recommendations, including schedules, age groups, and catch-up strategies.

Main Methods:

  • The recommendations are based on the latest available scientific evidence and epidemiological data.
  • The schedule incorporates routine vaccinations, booster doses, and specific vaccines for high-risk groups or travel indications.

Main Results:

  • The recommended schedule includes a 2+1 schedule for hexavalent (DTPa-VPI-Hib-HB) and 13-valent pneumococcal conjugate vaccines.
  • Key updates include a 6-year booster, Tdap vaccination in adolescents and during pregnancy, systematic rotavirus vaccination, and routine inclusion of Meningococcal B vaccine.
  • The schedule also recommends Meningococcal ACWY vaccine at 12 months (replacing MenC) and 12 years, universal HPV vaccination regardless of gender at 12 years, and specific schedules for MMR and varicella vaccines.

Conclusions:

  • The CAV-AEP's updated schedule aims to optimize protection against vaccine-preventable diseases in the Spanish pediatric population.
  • Emphasis is placed on achieving high coverage for all recommended vaccines, including newly incorporated ones like HPV and Meningococcal B.
  • The schedule provides a comprehensive framework for healthcare providers to ensure timely and complete immunization of children and adolescents.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...